Infectious Risk Mitigation in Patients with Multiple Sclerosis under Disease-Modifying Therapies – the Experience of a Collaborative Neurology-Infectious Diseases Approach

BACKGROUND: Multiple sclerosis treatment has changed in the last years with the emergence of new disease-modifying therapies (DMTs). Despite a better efficacy profile, these drugs raise concerns about infectious risk, which needs to be mitigated. OBJECTIVE: To analyze the results of a systematic col...

Descripción completa

Detalles Bibliográficos
Autores principales: Ferro, Daniela, Prista-Leão, Beatriz, Costa, Andreia, Silva-Pinto, André, Abreu, Cândida, Sá, Maria José
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2021
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8436289/
https://www.ncbi.nlm.nih.gov/pubmed/34526834
http://dx.doi.org/10.1177/11795735211042188

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8436289/
https://www.ncbi.nlm.nih.gov/pubmed/34526834
http://dx.doi.org/10.1177/11795735211042188

Ejemplares similares